November 22, 2017 – Addiction experts are always trying to find the most effective methods to treat the disease of addiction. At Malvern Institute, we only use an evidence-based, complete continuum of care, which includes Medication Assisted Treatment (MAT) options. A recent study confirmed the effectiveness of such programs.
The study, reported by the Los Angeles Times, claims that patients have a better opportunity for long-term recovery using MAT methods than undergoing only a detoxification process.
Medication Assisted Treatment combines FDA-approved medications, such as Vivitrol and Suboxone, with psychosocial therapy and support meetings to treat addiction to opiates and alcohol.
The report explains the study’s findings:
[T]he new study underscores that public policies that limit access to treatments such as methadone or buprenorphine don’t just shortchange patients who need help quitting; they’re costly to taxpayers footing the bill for their treatment as well.
If just one year’s worth of treatment-seeking opiate addicts were to get opioid agonist therapy instead of detox, the societal savings over the patients’ lifetimes would amount to $3.869 billion, the new study estimates.
Those patients would be in treatment longer, and the immediate cost of their treatment would increase, the new research finds. But over time, their increased likelihood of getting and staying clean would translate into lower downstream healthcare costs, a decreased likelihood of HIV infection (along with the costs of treating it), and less costly involvement with the criminal justice system.
Malvern Institute: We Give Hope
Read the full story on latimes.com.